Key Financial Data Of Group

STELLA PHARMA CORPORATION - Filing #7350910

Concept As at
2023-12-31
2023-10-01 to
2023-12-31
2023-04-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of group
Business results of group
Net sales
200,193,000 JPY
229,067,000 JPY
175,169,000 JPY
Ordinary profit (loss)
-466,654,000 JPY
-775,974,000 JPY
-480,498,000 JPY
Net assets
2,671,200,000 JPY
2,752,502,000 JPY
2,609,781,000 JPY
Total assets
3,926,718,000 JPY
4,329,053,000 JPY
4,053,152,000 JPY
Basic earnings (loss) per share
-5.24
-15.19
-26.97
-16.85
-4.85
Diluted earnings per share
Equity-to-asset ratio
0.678 xbrli:pure
0.633 xbrli:pure
0.641 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.